Alexander Tenenbaum

Summary

Affiliation: Tel Aviv University
Country: Israel

Publications

  1. doi request reprint Optimal revascularization in diabetes after the FREEDOM trial: Were the controversies finally settled?
    Alexander Tenenbaum
    Cardiac Rehabilitation Institute, Sheba Medical Center, 52621 Tel Hashomer, Israel
    Cardiol J 20:331-6. 2013
  2. pmc Balanced pan-PPAR activator bezafibrate in combination with statin: comprehensive lipids control and diabetes prevention?
    Alexander Tenenbaum
    Cardiac Rehabilitation Institute, Sheba Medical Center, 52621 Tel Hashomer, Israel
    Cardiovasc Diabetol 11:140. 2012
  3. pmc Fibrates are an essential part of modern anti-dyslipidemic arsenal: spotlight on atherogenic dyslipidemia and residual risk reduction
    Alexander Tenenbaum
    Cardiac Rehabilitation Institute, Sheba Medical Center, Tel Hashomer, Israel
    Cardiovasc Diabetol 11:125. 2012
  4. pmc Statins research unfinished saga: desirability versus feasibility
    Enrique Z Fisman
    Cardiovasc Diabetol 4:8. 2005
  5. pmc Long-term effects of peroxisome proliferator-activated receptor ligand bezafibrate on N-terminal pro-B type natriuretic peptide in patients with advanced functional capacity impairment
    Koichi Node
    Department of Cardiovascular and Renal Medicine, Saga University Faculty of Medicine, Saga, Japan
    Cardiovasc Diabetol 8:5. 2009
  6. ncbi request reprint Smoking and development of type 2 diabetes in patients with decreased functional capacity
    Alexander Tenenbaum
    Cardiac Rehabilitation Institute, Chaim Sheba Medical Center, Tel Hashomer, Israel Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
    Int J Cardiol 104:275-81. 2005
  7. ncbi request reprint Functional capacity impairment in patients with coronary artery disease: prevalence, risk factors and prognosis
    Alexander Tenenbaum
    Cardiac Rehabilitation Institute, Chaim Sheba Medical Center, Tel Hashomer 52621, Israel
    Cardiology 100:207-15. 2003
  8. ncbi request reprint Effect of bezafibrate on incidence of type 2 diabetes mellitus in obese patients
    Alexander Tenenbaum
    Cardiac Rehabilitation Institute, Chaim Sheba Medical Center, Tel Hashomer 52621, Israel
    Eur Heart J 26:2032-8. 2005
  9. pmc Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease?
    Alexander Tenenbaum
    Cardiac Rehabilitation Institute, Chaim Sheba Medical Center, Tel Hashomer, affiliated with Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
    Cardiovasc Diabetol 7:18. 2008
  10. pmc Dual and pan-peroxisome proliferator-activated receptors (PPAR) co-agonism: the bezafibrate lessons
    Alexander Tenenbaum
    Cardiac Rehabilitation Institute, Sheba Medical Center, 52621 Tel Hashomer, Israel
    Cardiovasc Diabetol 4:14. 2005

Collaborators

Detail Information

Publications72

  1. doi request reprint Optimal revascularization in diabetes after the FREEDOM trial: Were the controversies finally settled?
    Alexander Tenenbaum
    Cardiac Rehabilitation Institute, Sheba Medical Center, 52621 Tel Hashomer, Israel
    Cardiol J 20:331-6. 2013
    ..Therefore, although the results of the FREEDOM trial clearly demonstrated that CABG was superior to PCI in DM, a comparative analysis of the new incoming stents warrants further investigation. ..
  2. pmc Balanced pan-PPAR activator bezafibrate in combination with statin: comprehensive lipids control and diabetes prevention?
    Alexander Tenenbaum
    Cardiac Rehabilitation Institute, Sheba Medical Center, 52621 Tel Hashomer, Israel
    Cardiovasc Diabetol 11:140. 2012
    ....
  3. pmc Fibrates are an essential part of modern anti-dyslipidemic arsenal: spotlight on atherogenic dyslipidemia and residual risk reduction
    Alexander Tenenbaum
    Cardiac Rehabilitation Institute, Sheba Medical Center, Tel Hashomer, Israel
    Cardiovasc Diabetol 11:125. 2012
    ..Fibrates currently constitute an indispensable part of the modern anti-dyslipidemic arsenal for patients with atherogenic dyslipidemia...
  4. pmc Statins research unfinished saga: desirability versus feasibility
    Enrique Z Fisman
    Cardiovasc Diabetol 4:8. 2005
    ..In any case, conclusions based on surrogate endpoints cannot completely substitute head-to-head comparisons regarding patients' outcome...
  5. pmc Long-term effects of peroxisome proliferator-activated receptor ligand bezafibrate on N-terminal pro-B type natriuretic peptide in patients with advanced functional capacity impairment
    Koichi Node
    Department of Cardiovascular and Renal Medicine, Saga University Faculty of Medicine, Saga, Japan
    Cardiovasc Diabetol 8:5. 2009
    ..The current study aimed to investigate the long-term effects of bezafibrate on ProBNP level in patients with pre-existing CAD and advanced functional capacity impairment...
  6. ncbi request reprint Smoking and development of type 2 diabetes in patients with decreased functional capacity
    Alexander Tenenbaum
    Cardiac Rehabilitation Institute, Chaim Sheba Medical Center, Tel Hashomer, Israel Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
    Int J Cardiol 104:275-81. 2005
    ..The present study was aimed to evaluate the association between cigarette smoking and development of type 2 diabetes in patients with coronary artery disease and decreased functional capacity over a 6.2-year follow-up period...
  7. ncbi request reprint Functional capacity impairment in patients with coronary artery disease: prevalence, risk factors and prognosis
    Alexander Tenenbaum
    Cardiac Rehabilitation Institute, Chaim Sheba Medical Center, Tel Hashomer 52621, Israel
    Cardiology 100:207-15. 2003
    ..The present study was aimed to evaluate the outcome of CAD-related functional capacity impairment in patients with and without a history of MI over a 7.7-year follow-up...
  8. ncbi request reprint Effect of bezafibrate on incidence of type 2 diabetes mellitus in obese patients
    Alexander Tenenbaum
    Cardiac Rehabilitation Institute, Chaim Sheba Medical Center, Tel Hashomer 52621, Israel
    Eur Heart J 26:2032-8. 2005
    ..To assess the effect of fibric acid derivative bezafibrate on incidence of type 2 diabetes in obese patients over a median 6.3 years follow-up period...
  9. pmc Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease?
    Alexander Tenenbaum
    Cardiac Rehabilitation Institute, Chaim Sheba Medical Center, Tel Hashomer, affiliated with Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
    Cardiovasc Diabetol 7:18. 2008
    ..Therefore, we proposed to investigate a possible preventive effect of bezafibrate on the development of colon cancer in patients with coronary artery disease during a 6-year follow-up...
  10. pmc Dual and pan-peroxisome proliferator-activated receptors (PPAR) co-agonism: the bezafibrate lessons
    Alexander Tenenbaum
    Cardiac Rehabilitation Institute, Sheba Medical Center, 52621 Tel Hashomer, Israel
    Cardiovasc Diabetol 4:14. 2005
    ..More powerful new compounds with pan-PPAR activity and proven long-term safety should be highly effective in a clinical setting of patients with coexisting relevant lipid and glucose metabolism disorders...
  11. ncbi request reprint Macrovascular complications of metabolic syndrome: an early intervention is imperative
    Alexander Tenenbaum
    Cardiac Rehabilitation Institute, Chaim Sheba Medical Center, 52621 Tel Hashomer, Israel
    Int J Cardiol 97:167-72. 2004
    ....
  12. doi request reprint Optimal management of combined dyslipidemia: what have we behind statins monotherapy?
    Alexander Tenenbaum
    Cardiac Rehabilitation Institute, Chaim Sheba Medical Center, Tel Hashomer, Israel
    Adv Cardiol 45:127-53. 2008
    ....
  13. ncbi request reprint Insulin resistance is associated with increased risk of major cardiovascular events in patients with preexisting coronary artery disease
    Alexander Tenenbaum
    Cardiac Rehabilitation Institute, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
    Am Heart J 153:559-65. 2007
    ..The aim of our study was to explore the association between IR per se and cardiovascular events among patients with preexisting coronary artery disease...
  14. pmc Atherogenic dyslipidemia in metabolic syndrome and type 2 diabetes: therapeutic options beyond statins
    Alexander Tenenbaum
    Cardiac Rehabilitation Institute, The Chaim Sheba Medical Center, 52621 Tel Hashomer, Israel
    Cardiovasc Diabetol 5:20. 2006
    ....
  15. ncbi request reprint Peroxisome proliferator-activated receptor ligand bezafibrate for prevention of type 2 diabetes mellitus in patients with coronary artery disease
    Alexander Tenenbaum
    Cardiac Rehabilitation Institute, Chaim Sheba Medical Center, Tel Hashomer, 52621 Israel
    Circulation 109:2197-202. 2004
    ..2-year follow-up period...
  16. ncbi request reprint C-reactive protein as a predictor of incident ischemic stroke among patients with preexisting cardiovascular disease
    David Tanne
    Stroke Center, Department of Neurology and Sagol Neuroscience Center, Sheba Medical Center, Tel Hashomer, Israel
    Stroke 37:1720-4. 2006
    ..C-reactive protein (CRP) has emerged as an important predictor of cardiovascular disease, but there are few prospective data on its association with risk of ischemic stroke in patients at high risk...
  17. doi request reprint Calcification of the thoracic aorta as detected by spiral computed tomography among stable angina pectoris patients: association with cardiovascular events and death
    Alon Eisen
    Cardiac Rehabilitation Institute, Talpiot Medical Leadership Program, Chaim Sheba Medical Center, Tel Hashomer, Israel
    Circulation 118:1328-34. 2008
    ..The goal of the present study was to assess whether thoracic aorta calcification is associated with an increased risk of cardiovascular events and death in patients with stable angina pectoris...
  18. ncbi request reprint Coronary and aortic calcifications inter-relationship in stable angina pectoris: A Coronary Disease Trial Investigating Outcome with Nifedipine GITS (ACTION)--Israeli spiral computed tomography substudy
    Alon Eisen
    Cardiac Rehabilitation Institute, Department of Neurology, Sheba Medical Center, Tel Hashomer, Israel
    Isr Med Assoc J 9:277-80. 2007
    ....
  19. ncbi request reprint Bezafibrate for the secondary prevention of myocardial infarction in patients with metabolic syndrome
    Alexander Tenenbaum
    Cardiac Rehabilitation Institute, Neufeld Cardiac Research Institute, Chaim Sheba Medical Center, Tel Hashomer, Israel
    Arch Intern Med 165:1154-60. 2005
    ..We evaluated the effect of bezafibrate retard, a fibric acid derivative, on the incidence of MI in patients with MS enrolled in the Bezafibrate Infarction Prevention (BIP) study...
  20. ncbi request reprint Interleukin-6 and the risk of future cardiovascular events in patients with angina pectoris and/or healed myocardial infarction
    Enrique Z Fisman
    Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
    Am J Cardiol 98:14-8. 2006
    ..44; 95% confidence interval 1.57 to 8.13). In conclusion, elevated IL-6 levels are strongly associated with future cardiac events and mortality in a population with stable CAD during a long-term follow-up...
  21. ncbi request reprint Attenuation of progression of insulin resistance in patients with coronary artery disease by bezafibrate
    Alexander Tenenbaum
    Cardiac Rehabilitation Institute, Tel Hashomer, Israel
    Arch Intern Med 166:737-41. 2006
    ..The present analysis aimed to investigate the effect of bezafibrate on IR in patients with coronary artery disease enrolled in the Bezafibrate Infarction Prevention Study...
  22. ncbi request reprint Aortic valve calcification in hypertensive patients: prevalence, risk factors and association with transvalvular flow velocity
    Alexander Tenenbaum
    Cardiac Rehabilitation Institute, Chaim Sheba Medical Center, Tel Hashomer, Israel
    Int J Cardiol 94:7-13. 2004
    ....
  23. ncbi request reprint Functional class in patients with heart failure is associated with the development of diabetes
    Alexander Tenenbaum
    Cardiac Rehabilitation Institute, Neufeld Cardiac Research Institute, The Chaim Sheba Medical Center, Tel Hashomer, 52621 Israel
    Am J Med 114:271-5. 2003
    ..We followed patients with coronary artery disease who participated in the Bezafibrate Infarction Prevention study to determine the incidence of diabetes by baseline functional status during a 7.7-year follow-up...
  24. ncbi request reprint Spiral computed tomography evidence of close correlation between coronary and thoracic aorta calcifications
    Yehuda Adler
    Cardiac Rehabilitation Institute, Chaim Sheba Medical Center, Sackler Faculty of Medicine, Tel Hashomer, Tel Aviv University, Tel Aviv, Israel
    Atherosclerosis 176:133-8. 2004
    ..26-5.08, P = 0.006) were identified as independent variables for the prediction of thoracic aorta calcification. Conclusions: Our study demonstrated a strong association of CC and calcification of the thoracic aorta on spiral CT...
  25. ncbi request reprint Usefulness of helical computed tomography in detection of mitral annular calcification as a marker of coronary artery disease
    Yehuda Adler
    Cardiac Rehabilitation Institute, Chaim Sheba Medical Center, Sackler Faculty of Medicine, Tel Aviv University, Israel
    Int J Cardiol 101:371-6. 2005
    ..The goal of the present work was to investigate whether helical CT can determine the presence of MAC and to clarify its possible association with coronary artery disease (CAD) in elderly patients...
  26. doi request reprint Long-term changes in serum cholesterol level does not influence the progression of coronary calcification
    Alexander Tenenbaum
    Cardiac Rehabilitation Institute, The Chaim Sheba Medical Center, Tel Hashomer, Israel
    Int J Cardiol 150:130-4. 2011
    ..We tested the hypothesis that long-term changes in serum cholesterol (CL) would affect the progression of CC...
  27. ncbi request reprint Association of mitral annular calcium on spiral computed tomography (dual-slice mode) with thoracic aorta calcium in patients with systemic hypertension
    Yehuda Adler
    Cardiac Rehabilitation Institute, The Chaim Sheba Medical Center, Tel Hashomer, Israel
    Am J Cardiol 89:1420-2. 2002
  28. ncbi request reprint Impact of the metabolic syndrome on the clinical outcomes of non-clinically diagnosed diabetic patients with acute coronary syndrome
    Micha S Feinberg
    Heart Institute, Sheba Medical Center, Tel Hashomer, Sackler Faculty of Medicine, Tel Aviv University, Beer Sheba, Israel
    Am J Cardiol 99:667-72. 2007
    ..31) and 1.96 (95% confidence interval 1.18 to 3.24), respectively. In conclusion, MS defined early at admission is a strong independent predictor of mortality and morbidity in patients with non-clinically diagnosed diabetes with ACS...
  29. ncbi request reprint Calcification of the thoracic aorta by spiral computed tomography among hypertensive patients: associations and risk of ischemic cerebrovascular events
    David Tanne
    Stroke Center, Department of Neurology, Tel Hashomer, Israel
    Int J Cardiol 120:32-7. 2007
    ..Calcium is often deposited in the aorta, but the associations and clinical implications of calcification of the aorta have not yet been elucidated...
  30. ncbi request reprint Status of glucose metabolism in patients with heart failure secondary to coronary artery disease
    Alexander Tenenbaum
    Cardiac Rehabilitation Institute, Tel Aviv, Israel
    Am J Cardiol 90:529-32. 2002
  31. doi request reprint Relation of clinical benefit of raising high-density lipoprotein cholesterol to serum levels of low-density lipoprotein cholesterol in patients with coronary heart disease (from the Bezafibrate Infarction Prevention Trial)
    Ilan Goldenberg
    Heart Institute, Sheba Medical Center, Tel Hashomer, Israel
    Am J Cardiol 103:41-5. 2009
    ....
  32. ncbi request reprint Current smoking, smoking cessation, and the risk of sudden cardiac death in patients with coronary artery disease
    Ilan Goldenberg
    Heart Institute, The Chaim Sheba Medical Center, Tel Hashomer 52621, Israel
    Arch Intern Med 163:2301-5. 2003
    ..We, therefore, evaluated the effect of cigarette smoking on SCD risk in a large cohort of patients with established CAD...
  33. ncbi request reprint Is hypoglycaemia a marker for increased long-term mortality risk in patients with coronary artery disease? An 8-year follow-up
    Enrique Z Fisman
    Cardiac Rehabilitation Institute, Chaim Medical Center, Tel Hashomer, and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
    Eur J Cardiovasc Prev Rehabil 11:135-43. 2004
    ..We aimed to investigate the relationship between hypoglycaemia and all-cause, cardiovascular and cancer mortality in a large population of patients with CAD...
  34. ncbi request reprint Underuse of standard care and outcome of patients with acute myocardial infarction and chronic renal insufficiency
    Ariel Tessone
    Neufeld Cardiac Research Institute, Tel Aviv University, Tel Hashomer, Israel
    Cardiology 108:193-9. 2007
    ..To investigate characteristics, management and outcome of patients with acute myocardial infarction (AMI) and chronic renal insufficiency (CRI)...
  35. ncbi request reprint Coronary calcium by spiral computed tomography predicts cardiovascular events in high-risk hypertensive patients
    Joseph Shemesh
    Grace Ballas Research Unit of the Cardiac Rehabilitation Institute, Chaim Sheba Medical Center, Tel Hashomer and, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
    J Hypertens 22:605-10. 2004
    ..We aimed to investigate the hypothesis that CAC as assessed by dual slice spiral computed tomography (DSCT), is an independent risk factor for cardiovascular events in hypertensive patients...
  36. doi request reprint Coronary artery calcification predicts long-term mortality in hypertensive adults
    Joseph Shemesh
    Grace Ballas Research Unit of the Cardiac Rehabilitation Institute, The Chaim Sheba Medical Center, Tel Hashomer, Israel
    Am J Hypertens 24:681-6. 2011
    ..Coronary artery calcification (CAC) predicts mortality in normotensive individuals. We hypothesized that CAC has an impact on long-term mortality in hypertensive patients...
  37. ncbi request reprint Does participation in a long-term clinical trial lead to survival gain for patients with coronary artery disease?
    Alexander Tenenbaum
    Cardiac Rehabilitation Institute, Neufeld Cardiac Research Institute, Chaim Sheba Medical Center, Tel Hashomer, Israel
    Am J Med 112:545-8. 2002
    ....
  38. ncbi request reprint Combined coronary and mitral annulus calcium detection in the non-invasive diagnosis of coronary artery disease in patients with systemic hypertension
    Alexander Tenenbaum
    Cardiac Rehabilitation Institute, Chaim Sheba Medical Center, Tel Hashomer, Israel
    Coron Artery Dis 13:113-7. 2002
    ....
  39. ncbi request reprint Aortic valve calcium on spiral computed tomography (dual slice mode) is associated with advanced coronary calcium in hypertensive patients
    Yehuda Adler
    Cardiac Rehabilitation Institute, Chaim Sheba Medical Center, Tel Hashomer and Sackler Faculty of Medicine, Tel Aviv University, Israel
    Coron Artery Dis 13:209-13. 2002
    ..The goal of the present study was to determine whether an association exists between the presence of AVC and coronary calcium (CC) in high-risk hypertensive patients as detected by spiral computed tomography (dual slice mode) (DHCT)...
  40. doi request reprint Comparison of statin alone versus bezafibrate and statin combination in patients with diabetes mellitus and acute coronary syndrome
    Robert Klempfner
    Cardiac Rehabilitation Institute, Chaim Sheba Medical Center, Tel Hashomer, Israel, affiliated with the Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel Leviev Heart Institute, Chaim Sheba Medical Center, Tel Hashomer, Israel, affiliated with the Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel Israeli Society for the Prevention of Heart Attacks, Chaim Sheba Medical Center, Tel Hashomer, Israel, affiliated with the Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
    Am J Cardiol 113:12-6. 2014
    ..Signals regarding improvement of 30-day rehospitalization and 1-year mortality rates emerged as well...
  41. ncbi request reprint Transcutaneous detection of aortic arch atheromas by suprasternal harmonic imaging
    Ehud Schwammenthal
    Heart Institute and Cardiac Rehabilitation Institute, Tel Hashomer, Israel
    J Am Coll Cardiol 39:1127-32. 2002
    ..e., harmonic imaging from the suprasternal windows) can visualize protruding arch atheromas (PAAs) and reliably predict the presence or absence of significant lesions...
  42. pmc "If it ain't broke, don't fix it": a commentary on the positive-negative results of the ACCORD Lipid study
    Alexander Tenenbaum
    Cardiac Rehabilitation Institute, Sheba Medical Center, Tel Hashomer, Israel
    Cardiovasc Diabetol 9:24. 2010
    ..In patients without dyslipidemia this favorable effect - as expected - was absent...
  43. doi request reprint Left ventricular diastolic function in trained male weight lifters at rest and during isometric exercise
    Yehuda Adler
    Cardiac Rehabilitation Institute, Sheba Medical Center, Tel Hashomer, Israel
    Am J Cardiol 102:97-101. 2008
    ..0001 for all). In conclusion, intense resistance training leads to enhanced LV diastolic function at rest and during isometric exercise despite the markedly increased LV mass...
  44. ncbi request reprint Efficacy of omega-3 fatty acid supplementation in primary and secondary prevention of coronary heart disease
    Dalit Weisman
    Cardiac Rehabilitation Institute, Sheba Medical Center, Tel Hashomer, Israel
    Isr Med Assoc J 6:227-32. 2004
  45. pmc Effects of a vildagliptin/metformin combination on markers of atherosclerosis, thrombosis, and inflammation in diabetic patients with coronary artery disease
    Robert Klempfner
    Cardiac Rehabilitation Institute, Leviev Heart Center, Sheba Medical Center, 52621, Tel Hashomer, Israel
    Cardiovasc Diabetol 11:60. 2012
    ..Animal evidence indicates that dipeptidyl peptidase-4 inhibitors have anti-atherosclerotic effects, yet clinical data are scarcely available...
  46. pmc Cardiovascular events in patients received combined fibrate/statin treatment versus statin monotherapy: Acute Coronary Syndrome Israeli Surveys data
    Alexander Tenenbaum
    Cardiac Rehabilitation Institute, The Chaim Sheba Medical Center, Tel Hashomer, Israel
    PLoS ONE 7:e35298. 2012
    ..statin alone...
  47. pmc A cardiologic approach to non-insulin antidiabetic pharmacotherapy in patients with heart disease
    Enrique Z Fisman
    Sackler Faculty of Medicine, Tel Aviv University, 69978 Ramat Aviv, Tel Aviv, Israel
    Cardiovasc Diabetol 8:38. 2009
    ..In this context, it should be carefully taken into consideration whether the leading clinical status is CAD or heart failure...
  48. ncbi request reprint Impaired glucose metabolism in patients with heart failure: pathophysiology and possible treatment strategies
    Alexander Tenenbaum
    Cardiac Rehabilitation Institute, Sheba Medical Center, Tel Hashomer, Israel
    Am J Cardiovasc Drugs 4:269-80. 2004
    ..Treatment with HMG-CoA reductase inhibitors should probably now be considered routinely for all diabetic patients with CHF, irrespective of their initial serum cholesterol levels, unless there is a contraindication...
  49. ncbi request reprint Systemic hypertension in postmenopausal women: a clinical approach
    Enrique Z Fisman
    Cardiac Rehabilitation Institute, Chaim Sheba Medical Center, 52621 Tel Hashomer, Israel
    Curr Hypertens Rep 4:464-70. 2002
    ..Finally, education of both patients and physicians on the nature and prognosis of untreated hypertension is crucial...
  50. ncbi request reprint Long-term versus intermediate-term supervised exercise training in advanced heart failure: effects on exercise tolerance and mortality
    Alexander Tenenbaum
    Cardiac Rehabilitation Institute, Chaim Sheba Medical Center, Tel Hashomer, Israel
    Int J Cardiol 113:364-70. 2006
    ..We assessed exercise tolerance and mortality in CHF patients undergoing long- versus intermediate-term exercise training (ET)...
  51. ncbi request reprint Ischemic preconditioning: nearly two decades of research. A comprehensive review
    Alon Eisen
    Cardiac Rehabilitation Institute and Heart Failure Unit, Chaim Sheba Medical Center, Tel Hashomer, Israel
    Atherosclerosis 172:201-10. 2004
    ..Administration of these mimetic drugs or procedures could potentially advance the use of preconditioning as a therapeutic tool and/or preventive factor for cardiovascular disease...
  52. pmc "The metabolic syndrome... is dead": these reports are an exaggeration
    Alexander Tenenbaum
    Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
    Cardiovasc Diabetol 10:11. 2011
    ..A third step should probably be kept for bariatric surgery...
  53. ncbi request reprint Oral antidiabetic therapy in patients with heart disease. A cardiologic standpoint
    Enrique Z Fisman
    Cardiac Rehabilitation Institute, The Chaim Sheba Medical Center, affiliated to the Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
    Herz 29:290-8. 2004
    ....
  54. ncbi request reprint Autoantibodies to cardiolipin and beta-2-glycoprotein-I in coronary artery disease patients with and without hypertension
    Yaniv Sherer
    Department of Medicine B and Center of Autoimmune Diseases, Sheba Medical Center, Tel Hashomer, and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
    Cardiology 97:2-5. 2002
    ..Elevated levels of both antibodies have been reported in hypertension. Nonetheless, there are no data regarding an association between these autoantibodies and hypertension in coronary artery disease...
  55. doi request reprint Coronary calcium in patients with and without diabetes: first manifestation of acute or chronic coronary events is characterized by different calcification patterns
    Joseph Shemesh
    Sackler Faculty of Medicine, Tel Aviv University, 69978 Tel Aviv, Israel
    Cardiovasc Diabetol 12:161. 2013
    ..Aiming to elucidate these controversies we investigated the long-term outcome of coronary artery disease (CAD) in relation to degree of CAC in patients with and without DM from our annual cheek-up outpatient clinic...
  56. ncbi request reprint Admission blood glucose level and mortality among hospitalized nondiabetic patients with heart failure
    Alon Barsheshet
    Neufeld Cardiac Research Institute, Sheba Medical Center, Tel Hashomer 52621, Israel
    Arch Intern Med 166:1613-9. 2006
    ..We examined the possible association between admission glucose levels and outcome in a large cohort of hospitalized patients with HF...
  57. ncbi request reprint Aortic valve calcium on spiral computed tomography is associated with calcification of the thoracic aorta in hypertensive patients
    Yehuda Adler
    Cardiac Rehabilitation Institute, The Chaim Sheba Medical Center, Tel Hashomer, Israel
    Am J Cardiol 89:632-5. 2002
  58. doi request reprint Biomarkers in cardiovascular diabetology: interleukins and matrixins
    Enrique Z Fisman
    Cardiovascular Diabetology Research Foundation, Holon, Israel
    Adv Cardiol 45:44-64. 2008
    ..A pharmacologic simultaneous targeting of interleukins and matrixins might provide an effective means to concurrently control both atherosclerosis and diabetes...
  59. doi request reprint Non-insulin antidiabetic therapy in cardiac patients: current problems and future prospects
    Enrique Z Fisman
    Cardiovascular Diabetology Research Foundation, Holon, Israel
    Adv Cardiol 45:154-70. 2008
    ..New possibilities are represented by incretin mimetic compounds, dipeptidyl peptidase (DPP)-4 inhibitors, inhaled insulin and eventually oral insulin...
  60. ncbi request reprint Cardiovascular management of Marfan syndrome
    Michael Motro
    Ringers Unit for Clinical Cardiac Research, Sheba Medical Center, Tel Hashomer, Israel
    Isr Med Assoc J 10:182-5. 2008
  61. ncbi request reprint Effect of intensive resistance training on isotonic exercise Doppler indexes of left ventricular systolic function
    Enrique Z Fisman
    Cardiac Rehabilitation Institute, The Chaim Sheba Medical Center, Tel Hashomer, affiliated with the Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
    Am J Cardiol 89:887-91. 2002
  62. doi request reprint The metabolic syndrome entanglement: Cutting the Gordian knot
    Enrique Z Fisman
    Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel Cardiovascular Diabetology Research Foundation, Holon, Israel
    Cardiol J 21:1-5. 2014
    ..Therefore, currently available evidences strongly support the concept of the MS as a critical clustering of CV risk factors and diabetes, representing a true and solid evolving clinical entity. ..
  63. doi request reprint Annual acknowledgement of manuscript reviewers
    Alexander Tenenbaum
    Cardiac Rehabilitation Institute, Sheba Medical Center, Tel Hashomer 52621, Israel
    Cardiovasc Diabetol 13:18. 2014
    ....
  64. pmc Annual acknowledgement of manuscript reviewers
    Alexander Tenenbaum
    Cardiac Rehabilitation Institute, Sheba Medical Center, Tel Hashomer, 52621, Israel
    Cardiovasc Diabetol 12:43. 2013
    ....
  65. ncbi request reprint Bezafibrate and simvastatin: different beneficial effects for different therapeutic aims
    Alexander Tenenbaum
    J Clin Endocrinol Metab 89:1978; author reply 1978-9. 2004
  66. ncbi request reprint Long-term effect of bezafibrate on pancreatic beta-cell function and insulin resistance in patients with diabetes
    Helena Tenenbaum
    Endocrinology and Diabetes Unit, Dan Petah Tikva District, Clalit Health Services, Israel
    Atherosclerosis 194:265-71. 2007
    ..The present study was aimed to investigate the long-term effect of bezafibrate on these parameters in diabetic patients enrolled in the Bezafibrate Infarction Prevention (BIP) Study...
  67. ncbi request reprint C-reactive protein, bezafibrate, and recurrent coronary events in patients with chronic coronary heart disease
    Moti Haim
    Cardiology Department, Rabin Medical Center, Petach Tiqva, Israel
    Am Heart J 154:1095-101. 2007
    ....
  68. ncbi request reprint Cardiovascular diabetology: clinical, metabolic and inflammatory facets. Preface
    Enrique Z Fisman
    Adv Cardiol 45:xi-xiii. 2008
  69. ncbi request reprint [Type 2 diabetes mellitus and cardiovascular diseases: evaluation, treatment and prevention strategies]
    Morris M Mosseri
    Heart Institute, Hadassah Hebrew University Medical Center, Jerusalem, Israel
    Harefuah 145:141-6, 164. 2006
    ..This article reviews the current and emerging therapeutic strategies for these purposes from the cardiologists' point of view...
  70. ncbi request reprint Rhabdomyolysis and lipid-lowering drugs
    Alexander Tenenbaum
    JAMA 293:1448; author reply 1448-9. 2005
  71. ncbi request reprint Effects of peroxisome proliferator-activated receptor ligands, bezafibrate and fenofibrate, on adiponectin level
    Aki Hiuge
    Department of Metabolic Medicine, Graduate School of Medicine, Osaka University, 2 2, B5, Yamada oka, Suita, Osaka 565 0871, Japan
    Arterioscler Thromb Vasc Biol 27:635-41. 2007
    ..Effect of fibrates on adiponectin has not been clarified, whereas thiazolidinediones enhance adiponectin. Thus, we explored the possibility and mechanism that fibrates enhance adiponectin in humans, mice, and cells...
  72. ncbi request reprint Toward a redefinition of ischemic cardiomyopathy: is it an indivisible entity?
    Alexander Tenenbaum
    J Am Coll Cardiol 40:205-6; author reply 206. 2002